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The growing demand for various kinds of bone regeneration material has in turn 
increased the desire to find materials with optimal physical, chemical, and biolog-
ical properties. The objective of the present study was to identify the proportions 
of ceramic and polylactide components in a bone substitute material prepared in 
collaboration with the Crystal Chemistry of Drugs Team of the Faculty of Chem-
istry at the Jagiellonian University, which would be optimal for bone regeneration 
processes. Another goal was to provide a histological analysis of the influence of 
a ceramic-polylactide composite on the healing of osseous defects in rabbits. The 
study was performed on laboratory animals (18 New Zealand White rabbits).
The following study groups were formed:
–  group A (study group, 9 animals) – in this group we performed a histological 
analysis of healing with a ceramic-polylactide composite based on an 80/20 mix 
of hydroxyapatite and polylactide;
–  group B (study group, 9 animals) – in this group we performed a histological 
analysis of healing with a ceramic-polylactide composite with a reduced amount 
of hydroxyapatite compared to the previous group, i.e. in a ratio of 61/39;
–  group K (control, 18 animals) – the control group comprised self-healing, stan-
dardised osseous defects prepared in the calvarial bone of the rabbits on the con-
tralateral side. In the assessment of histological samples, we were also able to 
eliminate individual influences that might have led to differentiation in wound 
healing.
The material used in the histological analysis took the form of rabbit bone tissue 
samples, containing both defects, with margins of around 0.5 cm, taken 1, 3, and 
6 months after the experiment. 
The osseous defects from groups A and B filled with ceramic-polylactide material 
healed with less inflammatory infiltration than was the case with control group K. 
They were also characterised by faster regression, and no resorption or osteonecro-
sis, which allowed for better regeneration of the bone tissue. A statistical analysis 
of the study results revealed the increased resorptive activity of the composite in 
group B, which may have been due to its higher polylactide content. Simultane-
ously, we observed that healing of osseous defects filled with ceramic-polylactide 
composites in 80/20 and 61/39 ratios was comparable.
Key words: ceramic-polylactide composite, bone substitutes, bone regeneration, 
osteogenesis.
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Introduction
Surgical reconstruction helps restore the impaired tis-
sue integrity of the oral cavity as well as the functioning 
of such tissue. Aesthetic indications include, in partic-
ular, achieving symmetry by recreating the anatomical 
shape of the alveolar processes of the maxilla and alveo-
lar aspects of the mandibular base. Functional rehabili-
tation provides a basis for restoring the correct occlusal, 
masticatory, phonetic, and respiratory conditions.
Bone grafts and bone substitutes are used in differ-
ent areas of dentistry and various clinical procedures 
[1, 2]. They include:
A. Reconstructing the alveolar process:
• prosthetics:
–  increasing the height of the alveolar ridge of 
maxillary bones in cases of edentulism,
–  increasing the prosthetic area by reconstructing 
the margin of the alveolar ridge;
• implantology:
–  grafting of bone substitutes, 
–  maxillary sinus lift procedures,
–  filling-in osseous defects following inflammation 
of peri-implant tissue (periimplantitis);
• dental and maxillofacial surgery:
–  filling-in extensive, post-extraction osseous de-
fects in planned implant or prosthetic sites,
–  filling-in osseous defects after the following pro-
cedures: extraction of impacted teeth, cystecto-
my (when the radius of the cyst is greater than 
1 cm), removal of odontogenic tumours and be-
nign tumours in the maxilla and mandible, 
–  filling-in maxillary osseous defects following on-
cological procedures (only bone grafts);
• endodontics (endodontic surgery):
–  filling-in larger osseous defects following the re-
section of root apexes and the removal of peri-
apical lesions.
B. Assisting periodontal regeneration processes:
• filling-in deep pockets;
• filling-in grade II open root furcations for the pur-
poses of reconstructing lost bone in mandibular 
molars.
The most commonly used bone reconstructive 
materials are the following: bone materials of natural 
origin, i.e. bone from the same individual – autoge-
nous grafts, bone materials from an individual of the 
same species – allogenic grafts, and bone materials 
from another species – xenogeneic grafts. A second 
group comprises materials of synthetic origin as bone 
substitutes – alloplastic grafts [1, 3, 4].
Bone materials of natural origin – bone 
grafts
Autogenous bone material is taken from the 
patient undergoing the surgery and is grafted in 
a recipient site in the same patient. The material 
is comprised in 30% of an organic phase (collagen 
type I, non-collagen proteins) as well as in 70% of 
a non-organic phase (calcium phosphate) in the form 
of crystalline hydroxyapatite. It contains cells with 
osteogenic potential and factors that stimulate bone 
growth. It is characterised by osteoinductive and os-
teoconductive properties.
Allogenic materials are obtained from the human 
shafts of long bones. The donor and recipient are dif-
ferent genetically, but nevertheless still belong to the 
same species. Material of this type can be divided into 
2 groups: material containing living cells and mate-
rial devoid of living cells. The first category includes 
bone marrow cells and freeze-dried cancellous bone. 
The second category comprises demineralised freeze-
dried bone allografts (DFDBA), freeze-dried bone 
allografts (FDBA), fresh frozen bone (FFB), and au-
tolysed antigen-extracted allogenic bone (AAA). 
Xenogeneic (heterogeneic) materials are the most 
commonly used type of bone grafts. They fall into 
2 groups: materials taken from vertebrates and ma-
terials originating from invertebrates. Bone substi-
tutes obtained from bovine and porcine bones are in 
practice non-resorbable and biocompatible. They are 
produced in block and granule form and taken from 
both cancellous bone and compact bone, sometimes 
with an admixture of collagen. The preparation pro-
cess of the material is based on total deproteination 
under heat and ionising radiation. This reduces the 
immunogenicity of the product and the potential risk 
of transmission of zoonotic diseases. 
Bone materials of synthetic origin – 
alloplastic grafts
Bone substitutes have the following optimal prop-
erties [1, 5]:
• biocompatibility (no allergic, cytotoxic, and car-
cinogenic reactions).
• biologically safe (can be fully sterilised, asepsis),
• resorptive and substitutive properties similar to 
those of bone,
• degree of tissue resorption or degradation syn-
chronised with bone remodelling,
• low production costs,
• easy to store, 
• suitable mechanical properties for specific applica-
tions.
Alloplastic materials are applied as synthetic, re-
sorbable, or non-resorbable grafts. They are biocom-
patible, do not create any risk of cross infections, 
and possess osteoconductive potential. This group 
includes hydroxyapatite bioceramics, β-tricalcium 
phosphate (β-TCP), bioactive glass, artificial bone 
polymer, and ceramic-polylactide composites [1, 6, 
7, 8]. 
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Composite materials in medicine
A combination of hydroxyapatite with alpha-hy-
droxy acid polymers is known as a ceramic-polylactide 
composite. Composites possess a bone-like structure. 
They combine the osteoconductive properties of hy-
droxyapatite with the osteoinductive properties of 
polylactide. This combination enhances the mechanical 
properties of hydroxyapatite and has a positive modi-
fying effect on the inflammatory phase of the healing 
process. The use of crystals with dimensions not ex-
ceeding 200 mm in ceramic-polylactide composites can 
result in grafts with favourable mechanical properties. 
Moreover, they help avoid delamination at the margin 
of phases between the organic polymer matrix and the 
reinforcing mineral phase [9, 10, 11, 12].
At the present time, polymer-based composite 
materials are a very popular and rapidly developing 
area of research. Modifiers improve the weak me-
chanical properties of polymers, in particular their 
strength and fracture toughness, while at the same 
time also preserving the Young module at the level 
of bone elasticity. In addition, they change their bio-
logical properties by bestowing upon them the char-
acteristics of bioactivity. The first bioactive ceram-
ic-polylactide composite was polyethylene reinforced 
with hydroxyapatite, known under the brand name 
HAPEXTM HAPEXTM. In 1995 this composite was 
used to make a middle-ear implant with bone-like 
properties. It also proved to be a good base for osteo-
genic cell differentiation. Positive assessments from 
clinicians led to the development of other composites 
with polymer matrixes, i.e. polyetherketone (PEEK), 
polyhydroxybutyrate (PHB), and polylactide (PLLA). 
Studies conducted by Yang et al. demonstrated that 
intensive osteogenesis was achieved with a ceram-
ic-polylactide composite featuring xenogeneic bone 
marrow stromal cells embedded in vitro and grafted 
onto athymic mice [13, 14, 15, 16]. 
As with all medical products, implantation of a ce-
ramic-polymer composite is preceded by sterilisation, 
the aim of which is to destroy vegetative and spore 
forms of microorganisms. The choice of sterilisation 
method depends on the substances from which the 
medical product is produced [17, 18, 19, 20]. 
Ceramic-polylactide composites undergo deforma-
tion, thermal and oxidative degradation, as well as 
hydrolysis after being exposed to overheated water 
vapour, hot water, and high temperatures. As a re-
sult, they are sterilised with irradiation, and ethylene 
oxide gas [21, 22, 23].
Objective of study
The objectives of the study were as follows:
1.  Identify the proportions of ceramic and polylactide 
elements in experimental bone substitute material 
that would be optimal for bone regeneration.
2.  Provide a histological assessment of the influence 
of a ceramic-polylactide composite on the healing 
of osseous defects in rabbits.
Material and methods
The grafted ceramic-polylactide material was cre-
ated in collaboration with the Crystal Chemistry of 
Drugs Team of the Faculty of Chemistry at the Jagi-
ellonian University. On account of a patent applica-
tion being filed for the ceramic-polylactide compos-
ite, a description of how it is obtained is presented 
here only in a general way, so as to ensure exclusive 
rights are maintained. Synthetic hydroxyapatite was 
obtained using the precipitation method described by 
Komlev (Fig. 1, 2) [24]. Granules with dimensions of 
250-1000 µm were covered with a poly-(D,L lactide) 
layer with an average molecular weight of 80 kDa, 
which made up 20% (group A) and 39% (group B) of 
the graft mass. For the coating of granules, a meth-
Fig. 2. Scanning Electron Microscope (SEM) image of 
composite granule with diameter of approximately 600 µm 
(magnification 800×)
Fig. 1. Scanning Electron Microscope (SEM) image of 
composite granule with diameter of approximately 600 µm 
(magnification 110×)
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od of polymer dissolution in a solvent (acetone) was 
used. The solution was then mixed and granules add-
ed to it, which were then dried on a polystyrene sub-
strate. Prior to the commencement of the study the 
material was sterilised with ethylene oxide. 
The study was performed on a group of eighteen 
closely-related New Zealand white rabbits, aged 
9-12 months, and weighing 3.0 to 4.0 kg. They came 
from 4 litters and from the same parents. For pro-
phylactic purposes the rabbits were dewormed 6 and 
1.5 months prior to the procedure and vaccinated 
against myxomatosis and pests as a protective mea-
sure 4 weeks prior to the procedure. The rabbits were 
given no food for 12-18 hours prior to the experi-
ment, but had free access to water. All the proce-
dures were performed in the Animal Reproduction 
Biotechnology Department of the Institute of Zoo-
technics – the State Research Institute in Balice.
The following study groups were formed:
• group A (study group, nine animals) – in this 
group we performed a histological analysis of heal-
ing with a ceramic-polylactide composite based on 
an 80/20 mix of hydroxyapatite and polylactide;
• group B (study group, nine animals) – in this group 
we performed a histological analysis of healing in-
volving a ceramic-polylactide composite with a re-
duced amount of hydroxyapatite compared to the 
previous group, i.e. in a ratio of 61/39;
• group K (control, 18 animals) – the control group 
comprised self-healing, standardised osseous de-
fects, prepared in the calvarial bone of the rabbit 
on the contralateral side. Individual influences 
that might have caused differences in healing were 
in this way additionally eliminated when assessing 
the histological samples.
All surgical procedures were conducted in ac-
cordance with the experimental model for the New 
Zealand White rabbit devised by the Krakow team 
from the Chair and Clinic of Cranio-Maxillo-Facial, 
Oncological, and Reconstructive Surgery at the Jagi-
ellonian University Medical College [25, 26]. 
Consent for the study was obtained from the Local 
Krakow Ethics Committee at the Institute of Phar-
macy of the Polish Academy of Sciences (Consent no. 
746/2010)
A histological analysis was performed on rabbit 
bone tissue samples containing both defects, tak-
en 1 month (M1) (Fig. 3), 3 months (M3) (Fig. 4), 
and 6 months (M6) (Fig. 5) after the experiment. 
Prior to taking the study material, the rabbits re-
ceived pre-medication (2% Rometar, Spofa, Czech 
Republic). After being sedated they were euthanised 
(Morbital, Biowet, Poland) according to the formula 
devised by the Animal Reproduction Biotechnology 
Department of the Zootechnics Institute in Balice. 
After being transferred to the operating theatre the 
experimental sites with a margin (0.5 cm) of healthy 
tissue [27] were excised. 
The samples were assessed under an optical micro-
scope by an experienced pathomorphologist. A de-
tailed description of individual lesions was recorded 
and photographic documentation prepared. 
The next step in histological evaluation was to 
measure the amount of bone healing, which was 
defined between the bottom of the cavity and the 
highest point of filling the cavity. For the measure-
ment expressed in absolute terms (microns) histo-
logical preparations were used made from scraps of 
bone from the centre of each bone defect. Image 
processing for measurements were performed using 
an Axioscope microscope (Zeiss GmbH, Germany) 
with a Plan Neo Fluar 2.5× lens (Carl Zeiss Micro-
Imaging GmbH, Germany) and an MC1000 camera 
(Motic Corp., China), connected to a standard PC us-
ing AnalySIS image Pro 3.2 (Soft Imaging Systems 
Fig. 3. Sample of frontal bone of rabbit one month after 
procedure (M1)
Fig. 4. Sample of frontal bone of rabbit three months after 
procedure (M3) 
Fig. 5. Sample of frontal bone of rabbit 6 months after 
procedure (M6)
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GmbH, Germany) for analysis. The measurements 
were made using the language Imaging C, perform-
ing user interaction. The results were saved in a text 
file and then imported to Excel 2010 (Microsoft 
Corp., USA). 
Morphometric studies were used to assess the se-
verity of the healing process of the bone and due to 
the type of filling material wound. Used to describe 
the arithmetic mean (average), standard deviation, 
median, the smallest value (minimum), and maxi-
mum value (maximum). To evaluate the distribu-
tion of the studied traits in the groups analysed in 
the months to follow-up, the Shapiro-Wilk test was 
used. Verification of the differences between the 2 
groups was performed using Student’s t test or the 
Mann-Whitney test. The calculations were carried 
out using the statistical package STATISTICA. Ver-
ification of statistical hypotheses were carried out at 
the level of significance a = 0.05.
Results
A month after the experiment the dominant fea-
ture observed in the histological images for groups 
AM1 and BM1 was a build-up of fibrous connective 
tissue, which formed round spaces in the area sur-
rounding the material. The following were visible: 
osteoclasts, individual macrophages, polymorphonu-
clear giant cells, necrotic trabeculae, and resorption 
type granulation (Fig. 6). 
In the KM1 group necrotic trabeculae were ob-
served at the base of the defects. In the remaining 
area we observed resorption as well as remodelling of 
the trabeculae with osteoclast participation together 
with a build-up of fibrous tissue. In one case, consid-
erable giant cell granulation was visible (Fig. 7). 
After 3 months a build-up of fibrous connective 
tissue was evident in groups AM3 and BM3, which 
formed round spaces in the area surrounding the ma-
terial. In 5 cases, giant-cell reaction was visible. In 1 
case, necrotic trabeculae were present. In 2 cases new 
trabeculae formed in connective tissue septa between 
the spaces containing remnants of the bone substi-
tute material (Fig. 8).
Fig. 7. Fibrous tissue and giant cell granulation in defect 
without graft after one month of healing (HE stain, mag-
nification 100×)
Fig. 8. Bands of fibrous tissue separates spaces with bone 
substitute material after three months of healing (HE stain, 
magnification 100×)
Fig. 6. Defect with graft filled with fibrous tissue and ne-
crotic trabeculae 1 month after healing (HE stain, magni-
fication 200×)
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In 5 cases in the KM3 group fibrous connective 
tissue containing spaces lined with endothelium had 
built up in the defect area. There were some places of 
cellular abundance. In several cases small numbers of 
necrotic trabeculae were visible. Forming trabeculae 
were observed in other samples (Fig. 9).
A build-up of fibrous connective tissue was visible 
after 6 months in groups AM6 and BM6 with spac-
es containing remnants of biomaterial. Bone tissue 
with cementum lines had built up in these areas. Also 
present were spaces lined with endothelium and os-
teoblasts forming linear systems (Fig. 10).
In the KM6 group osseous defects contained ne-
crotic trabeculae with characteristics of resorption. 
A considerable volume of fibrous cell tissue featuring 
submerged slit-like vascular spaces was present in the 
surrounding area. Fibrotic processes affected the en-
tire thickness of the laminar bone. In 2 cases we ob-
served intense bone tissue formation with osteoblast 
proliferation (Fig. 11, 12).
Group A and group B showed significantly high-
er amounts of healing than the control group at one 
month follow-up (p = 0.007; p = 0.003) and at 
6 months follow-up (p = 0.010; p = 0.003). There 
were no statistically significant differences between 
the groups at three months follow-up. There were no 
significant differences between groups A and B. The 
results are shown in Table I.
Fig. 9. Fibrous tissue between trabeculae after three 
months of healing (HE stain, magnification 200×)
Fig. 11. Trabeculae with cementum lines, spaces lined with 
endothelium and osteoblasts forming linear systems after 6 
months of healing (HE stain, magnification 200×)
Fig. 12. Numerous osteoblasts, forming continuous layer 
on surface of trabeculae
Fig. 10. Fibrous tissue with forming trabeculae bone after 
6 months of healing. (HE stain, magnification 100×)
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Discussion
Over the last few years reconstructive surgery has 
undergone a period of intensive development, which 
has led to an increase in demand for various kinds of 
grafting materials. Bone transplant procedures are 
used widely in maxillofacial surgery, plastic surgery, 
periodontology, orthopaedics, and neurosurgery. Bone 
is the second most commonly grafted tissue in the 
human body after blood. The regeneration processes 
that accompany transplantation procedures depend on 
4 factors: osteogenic cells (osteoblasts or stem cells), 
osteoinductive signals conveyed through growth fac-
tors, an osteoinductive matrix that ensures suitable 
scaffolding, blood, and nutritional factors. The only 
material that meets all the criteria is autogenous bone, 
the use of which, however, is associated with a high 
(8-39%) risk of such complications as infection, hae-
matoma, nerve damage, and the occurrence of chronic 
pain in the donor site. In the case of larger defects, ob-
taining a suitable amount of graft material may prove 
problematic. In light of this fact bone substitutes are 
attracting a great deal of interest [28, 29]. 
Bone tissue regeneration based on biologically 
compatible materials is proceeding in the same way 
as bone wound healing. The only difference is that 
after the graft has been placed in the defect, there is 
additionally a reaction to foreign bodies accompanied 
by temporary inflammation, and even traces of ne-
crosis. The histological picture is dominated by mac-
rophages and polymorphonuclear giant cells. The 
desired phenomenon is the presence of blood in the 
osseous bed. Good absorption of glycoproteins, lipo-
proteins, and platelets into the graft surface allows 
for activation of a coagulation cascade and comple-
ment system. The clot that forms during this pro-
cess provides scaffolding from fibrin, fibronectin, and 
hyaluronic acid and with the help of adhesive bonds 
increases the attraction of circulating growth factors 
and cytokines. This helps trigger angiogenesis and 
the chemotactic migration of undifferentiated cells, 
which in later stages of healing undergo differentia-
tion in an osteoblast direction [30, 31].
Hydroxyapatite ceramics, which have long been 
used in such procedures, have the highest biocom-
patibility and bioactivity properties of all well-known 
implant materials. Hydroxyapatite substrate is an os-
teoconductive and to a lesser extent osteoinductive 
material, thanks to which implants made from it 
have the ability to bind with bone. To achieve proper 
bonding with the bone it is important to ensure close 
and precise adhesion of the graft to the bone together 
with its mechanical post-operative stability [32]. 
Chłopek et al. grafted lactide copolymer and gly-
colide together with a composite of this copolymer 
with hydroxyapatite to the mandible of a New Zea-
land rabbit. They observed that resorption of both 
materials commenced from the third week of implan-
tation. The creation of bone tissue in the case of the 
composite proceeded in parallel with the resorption 
of the polymer and occurred in both hydroxyapatite 
particles and in formed collagen fibres. The percent-
age of connective tissue following application of the 
polymer itself was much higher than in the case of 
the composite throughout the entire observation pe-
riod [33]. 
The author’s own study revealed that resorption 
of ceramic-polylactide material in group A was min-
imal, while in group B there was a significant reduc-
tion in the diameter of the granules. This result may 
suggest that a composite containing an increased 
amount of polylactide in relation to hydroxyapatite 
may have high resorption activity. In spite of this fact, 
no statistically significant differences were observed 
between the study groups that had any influence on 
bone healing (assessed morphometric parameters). 
In a study conducted by Magdziarz on 57 rabbits, 
the author drew attention to the impact of a compos-
ite comprising copolymer PLLA/GLA and hydroxy-
apatite on the healing of osseous defects in rabbits. 
























AM1 i KAM1 1027.1 141.4 995.5 904.1 1181.5 703.7 111.8 705.7 570.8 845.2 0.007
AM3 i KAM3 979.6 107.0 1020.2 858.2 1060.4 776.4 271.7 790.8 375.7 1213.3 0.264
AM6 i KAM6 1150.5 196.7 1155.3 951.5 1344.8 786.0 122.4 775.2 587.0 959.2 0.010
BM1 i KBM1 992.2 14.6 995.2 976.3 1005.0 703.7 111.8 705.7 570.8 845.2 0.003
BM3 i KBM3 1180.7 167.5 1182.0 1012.5 1347.5 776.4 271.7 790.8 375.7 1213.3 0.053
BM6 i KBM6 1149.0 91.6 1162.9 1051.2 1232.8 786.0 122.4 775.2 587.0 959.2 0.003
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No local or systemic tissue reactions were observed. 
Bone tissue healing was barely noticeable at the end 
of a 6-week observation period, and yet after 12 
weeks the healing process was finished completely. 
A comparison with the control group revealed that 
faster bone healing was achieved when a composite 
was implanted [34]. The results of our own histolog-
ical analyses of bone tissue samples taken from ex-
perimental animals confirmed the positive influence 
of a ceramic-polylactide composite on bone tissue 
formation. 
According to our own observations, the time 
needed to complete bone regeneration is around 6 
months, which differs significantly from Magdziarz’s 
experiments. Zhang et al. also reported different re-
sults. They grafted a hydroxyapatite and polyam-
ide composite onto the mandible of a New Zealand 
White rabbit. The bone had finished healing half 
a year after implantation [35].
Ignjatovic et al. conducted an in vivo study on 
a composite HAp/ PLLA biomaterial implanted into 
the femur of a Balb/C mouse. They demonstrated 
good adhesion and expression of cells responsible for 
bone regeneration on the surface of the ceramic-poly-
mer biomaterial [36, 37, 38].
Histology tests conducted by the author a month 
after the procedure revealed the build-up of fibrous 
tissue in osseous defects filled with bone substitutes. 
This tissue included regular, round spaces containing 
the remnants of implantation material. No inflam-
matory cells were observed nor any foreign body re-
action in bones. Observations after 3 months revealed 
the formation of new trabeculae, for the most part 
poorly organised. Six months after the beginning of 
the experiment the trabeculae had formed a regular 
system with osteoblasts arranged in a linear series.
In one case necrotic trabeculae were present, ac-
companied by purulent inflammatory infiltration, 
which may have indicated a bacterial infection. His-
tological images revealed peripheral polymer resorp-
tion, and in central parts fragments of hydroxyap-
atite had become overgrown with new bone tissue. 
Macroscopic tests performed after 3 months con-
firmed that the defects had gradually filled with new 
bone tissue. In both groups implantation sites dif-
fered significantly from the surrounding area. After 6 
months the operating fields were recognisable only in 
the form of slight differences in colouring. 
Conclusions
The study method proved its usefulness in achiev-
ing the study objectives.
Compared with control group K the osseous de-
fects in groups A and B filled with ceramic-polylac-
tide material healed with less inflammatory infiltra-
tion and faster regression, and exhibited no resorption 
or osteonecrosis, which ensured better regeneration 
of bone tissue.
A statistical analysis of the study results revealed 
the greater resorption capability of the composite in 
group B, which may have been due to its higher poly-
lactide content. Simultaneously, we observed compa-
rable healing of osseous defects filled with ceram-
ic-polylactide composites in 80/20 and 61/39 ratios. 
The use of a ceramic-polylactide material induces 
differentiation of mesenchymal cells into osteoblasts, 
which initiates osteogenesis. This mechanism has not 
been fully explained and should be the object of fur-
ther studies.
The authors declare no conflict of interest.
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